StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis YoY Growth in the U.S. by Quarter

YoY Growth in the U.S. (% USD / cc) (%)

QuarterlyAnnual

Novartis YoY Growth in the U.S.: 9.0% in Q3 2026, down 44.0 pts from a year earlier.

Latest, Q3 2026
9.0%
Period ended Sep 30, 2026
Change on a year earlier
-44.0 pts
53.0% in Q3 2025
History
13 quarters
Since Q3 2023
Sources
13
Documents cited below

Where the Q3 2026 figure comes from

“|| Pluvicto | Oncology | PSMA-positive mAPMN/S, mAPMR patients post-ARPI, pre- and post-Taxane | 502 | 9 | 172 | 65 | 68 | 674 | 20 | 20”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K & Form 20-F.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedYoY Growth in the U.S. (% USD / cc) (%)Year on yearSource
Q3 2026Sep 30, 20269.0%-44.0 ptsNovartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 202638.0%+17.0 ptsNovartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 202676.0%+74.0 ptsNovartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 202575.0%+63.0 ptsNovartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 202553.0%+27.0 ptsNovartis Form 6-K (0001114448-25-000003) ↗
Q2 2025Jun 30, 202521.0%-9.0 ptsNovartis Form 6-K (0001370368-25-000012) ↗
Q1 2025Mar 31, 20252.0%-35.0 ptsNovartis Form 6-K (0001370368-25-000010) ↗
Q4 2024Dec 31, 202412.0%-36.0 ptsNovartis Form 6-K (0001370368-25-000007) ↗
Q3 2024Sep 30, 202426.0%-196.0 ptsNovartis Form 6-K (0001370368-24-000022) ↗
Q2 2024Jun 30, 202430.0%–Novartis Form 6-K (0001370368-24-000019) ↗
Q1 2024Mar 31, 202437.0%–Novartis Form 6-K (0001370368-24-000017) ↗
Q4 2023Dec 31, 202348.0%–Novartis Form 6-K (0001370368-24-000007) ↗
Q3 2023Sep 30, 2023222.0%–Novartis Form 6-K (0001370368-23-000068) ↗

Cite this data

StockData. (2026). Novartis YoY Growth in the U.S. (%), quarterly Q3 2023–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/brand-pluvicto-us-yoy-pct

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.